FOX04 DRI
FOX04 DRI
Research Use Only and not for human consumption. Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance.
Couldn't load pickup availability
Description
FOXO4-DRI
FOXO4-DRI (FOXO4-D-Retro-Inverso) is a senolytic peptide. It is used in research to reduce age-related dysfunction, improve physical stamina, and restore tissue homeostasis, largely by allowing p53 to trigger self-destruction in damaged cells. FOXO4-DRI is considered a promising approach in anti-aging research. It works by ensuring that the senescent cells are removed in a clean and safe way, reducing the risk of further damage to surrounding tissues.
- Selective Elimination of Senescent Cells:
It removes damaged "zombie" cells that accumulate with age, which contributes to chronic inflammation and tissue degeneration. - Improved Physical Condition and Energy:
In studies on aging mice, treatment was associated with improved fitness, reduced frailty, and increased overall energy levels. - Reduced Inflammation and Improved Tissue Function:
It helps reduce senescence-associated secretory phenotype (SASP), lowering chronic inflammation. - Improved Renal Function:
Studies show that it can help reverse signs of aging in the kidneys. - Improved Hair Density: Studies on aged mice noted an increase in hair density following treatment.
-
Improved Fertility:
It has been shown to improve spermatogenesis and increase sperm quality in aging mice. - Anti-Aging Effects on Vascular System:
It has been found to suppress aortic aging and improve aortic function
